13/01/2019
💐 💐
:
Main factors which determine treatment is severity of disease activity, organs involved and patients associated health conditions such as pregnancy etc. General principles are discussed here.
Drugs required are mainly targeting for following reasons:
1: immunosuppressive drugs
2: antiplatelets &/or anticoagulation for APLS or TTP related issues
3: CVS risk factors modification &/or
4: symptom based therapy
HYDROXYCHLOROQUIN:
Every patient of SLE should be on HCQ unless it’s contraindicated . It works as being immundomodulator by getting stored in macrophages and alkalikising the pH and reducing their ability for inflammation. In addition to its effects on reducing inflammation, it also reduces thrombotic tendency, osteoporosis and disease progression. Renal disease or liver disease will need dose reduction as its metabolism & excretion will be affected.
Main side effect is dose and duration dependent retinal deposition especially in Macula requiring annual monitoring which usually causes issues after several (more than 5-6 years of use). It’s usually enough for mild SLE affecting skin & musculoskeletal system. It’s SAFE in pregnancy.
METHOTREXATE:
Being antifolate,it reduces cell division & hence reduces blood cells including immune cells.
It’s mainly used & is drug of first choice for musculoskeletal manifestations (Joint, muscles & skin) of any Rheumatological diseases including SLE, RA, Psoriasis etc. It’s usually added to HCQ if the later alone isn’t enough for musculoskeletal features of SLE or RA. Also Anything more than Mild disease of musculoskeletal parts need MTX unless contraindicated.
Internal organ involvement usually doesn’t benefit much from MTX. It’s not safe for pregnancy. Patients needs folate replacement too to save normal body cells. Maximum dose is 25mg/week.
S/E include cytopenia, liver damage (fibrosis etc ) , penuominitis and Lung fibrosis, teratogenic and also cause abortion, GI upset etc.
ORGAN INVOLVEMENT in SLE (KIDNEY, LUNG, CNS, VASCULITIS etc ):
It needs aggressive immunosuppressive therapy to save permanent damage by inflammation and /or thrombosis. Two phases of treatment include Induction followed by maintainance. Induction is achieved by Steroids with Cyclophosphamide or steroids with Mycophenolate. Maintainince is by MMF or Azathioprine or MTX.
INDUCTION by 1 OR 2:
1: Generally speaking IV Methylprednisolone pulse therapy (1 gm daily for 3-5 days) followed by oral prednisolone 1mg/kg ideal weight/day along with Cyclophosphamide (C*C) monthly pulse therapy (750-1000 mg /m2 body surface area/month ) is treatment of choice. Low dose C*C such as 500 mg/m2 body area/ fortnight for 6 doses etc can also be considered for European descent patients whose response to low dose is almost similar to high dose. Oral C*C daily has almost similar efficiency but significantly more cumulative toxicity but is often used in resource limited countries. Main side effects are cytopenia, infections, haemorrhagic cystitis & bladder TCC, vasoconstriction related side effects, teratogenicity and infertility. Not safe in reproductive age patients who can be pregnant or want children. MESNa is antidote usually given with C*C.
2: In the above regimen if C*C toxicity is major concern such as young patients with fertility related aspects etc, MYCOPHENOLATE (MMF) (2-3gm/day) can be substituted for C*C but steroids regimen would remain the same. MMF has similar efficacy as C*C but with much lesser toxicity. Mycophenolic Acid or Mycophenolic Na has relatively lesser GI upset than Mycophenolate. Main dude effects are cytopenia & teratogenicity. It’s Not safe in pregnancy.
MAINTAINANCE THERAPY:
Once disease remission is achieved by induction therapy, maintainince is preferably by MMF (2 gm/day). Second choice is Azathioprine (2-3 mg/kg/day & used only if TPMT enzyme assay is normal) & third choice is by MTX. This preference is due to efficacy.
AZA (Azathioprine) is safe in pregnancy so it’s preferred for reproductive age or pregnant patients. However it’s not as effective as MMF. Check TPMT enzyme assay before using AZA as if it’s low patients marrow toxicity is greatly increased. Main side effects are cytopenia & liver derangement in addition to malignancies in long term use.
FAILED INDUCTION THERAPY or RESISTANT TO C*C /MMF & Steroids:
Options are switching to C*C if MMF failed OR switching to MMF if C*C failed but Steroids would be given along with each option.
Second option is biological agents such as Rituximab or Belimumab therapy.
Severe life threatening emergencies such as TTP, Pulmonary Haemorrhage, hyper gamma globulinemia, biological resistant disease etc may need plasmapharesis or IVIG.
CYTOPENIA & LUPUS
Use CNI (Cyclosporine), IVIG etc (but avoid C*C, AZA, Leflunomide & MTX if possible as they cause cytopenia).
PREGNANCY & SLE:
HCQ, Prednisolone, sulfasalazine with folic acid, Azathioprine up to 2 mg/kg/day , low dose calcinurin inhibitors (Cyclosporine & Tacrolimus ) & IVIG are safer. Details in a separate post.